title: [Two cases of pituitary metastases as initial presentation form of small cell lung cancer].
abstract: Metastases in the sellar region are rare and are frequently found incidentally or in necropsies. Only 7% are reported to be symptomatic. Diabetes insipidus, anterior pituitary dysfunction, visual field defects, headache/pain and ophthalmoplegia are the most commonly reported symptoms. We present the cases of two male patients with a small-cell lung carcinoma whose first clinical symptoms were due to pituitary metastasis. One case presented with symptoms of cavernous sinus invasion and panhypopituitarism and the other case with diabetes insipidus. Both patients had a rapid progression of their disease despite chemotherapy and died after a few months. Pituitary metastases occur most commonly with breast cancer in women and lung cancer in men. The presence of polyuria and polydipsia in an oncologic patient should alert the physician for diabetes insipidus and, if confirmed, an imaging procedure of the pituitary gland is mandatory. Treatment for these tumors is often multimodal and includes surgery, radiation therapy, chemotherapy and hormone replacement. Although surgical series have not shown any significant survival benefits given by tumor resection, the patient's quality of life may be improved.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital del Mar de Barcelona, España. 96002@paredesalutmar.cat
authors.forename: David
authors.initials: D
authors.lastname: Benaiges
authors.forename: Montserrat
authors.initials: M
authors.lastname: Zanui
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Chillaron
authors.forename: Edurne
authors.initials: E
authors.lastname: Arriola
authors.forename: Laia
authors.initials: L
authors.lastname: Garrigos
authors.forename: Juan
authors.initials: J
authors.lastname: Pedro-Botet
mesh_terms: D000368:Aged; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D010911:Pituitary Neoplasms / Q000556:secondary*; D055752:Small Cell Lung Carcinoma / Q000556:secondary*